LDL cholesterol as a causal agent of atherosclerosis Juan Pedro-Botet; Elisenda Climent; David Benaiges;

How to achieve LDL cholesterol goals with the funding criteria for new lipid-lowering drugs? Antón González-Guerrero; Elisenda Climent; David Benaiges; Juan Pedro Botet;

Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study Àlex Vila; Estel Pons; Patricia Trinidad García; Daniel Vidal; Sara López; Armand Grau;